China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.
Browsing: type 2 diabetes
The approval of Novo Nordisk’s diabetes drug Victoza has led to an unintended benefit for a competitor.
VIVUS, a pharmaceutical company specializing in products to treat sexual function, announced that their experimental obesity drug Qnexa was shown to improve blood sugar control in patients with type 2 diabetes.
Investment website The Motley Fool has published a list of five stocks approaching greatness–and four of them are within the life sciences industry.